icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Profits yield dividends at Veropharm

Profits yield dividends at Veropharm
Leading Russian pharmaceutical producer Veropharm, has posted a 1H 2011 net Profit of 880.6 million rubles under IFRS.

he bottom line is up 20.7% on the 1H 2010 net profit of 729.4 million roubles, with EBITDA up by 16.9% year-on-year to 1.1 million roubles on the back of consolidated sales revenues rising 18% year-on-year to 3.2 billion roubles compared with 2.7 million in H1 2010.

The company mentioned a sales increase in two of the main pharmaceutical product groups including a 16.4%increase in sales of Rx drugs and a 32.2% increase in OTC drugs sales. However, traditional drug sales were down 55.1%year-on-year compared to H1 2010, resulting in a decrease in sales of these products in the total sales volume to 0.4%.

The Veropharm general shareholders meeting has decided to allocate in H1  190 million roubles of 2010 dividends.